Table 1 Subject Characteristics
From: Differences in MAP kinase phosphorylation in response to mechanical strain in asthmatic fibroblasts
Group | Sex | Age | PC20 | FEV1(%) | Atopy | Medication |
|---|---|---|---|---|---|---|
Asthmatic | M | 24 | 2.33 | 4.03 (98) | Yes | β-agonist only |
Asthmatic | F | 20 | 4.21 | 3.51 (105) | Yes | β-agonist only |
Asthmatic | M | 20 | 2 | 4.22 (98) | Yes | β-agonist only |
Asthmatic | F | 18 | 0.56 | 3.09 (36) | Yes | β-agonist only |
Asthmatic | M | 18 | 0.66 | 4.29 (94) | Yes | β-agonist only |
Asthmatic | F | 22 | 0.14 | 3.55 (93) | Yes | β-agonist only |
Asthmatic | M | 26 | saline | 3.77 (82) | Yes | β-agonist only |
Asthmatic | M | 26 | 3.11 | 4.00 (76.7) | Yes | β-agonist only |
Mean | 21.8 ± 3.3 | 1.9 ± 1.5 | 3.8 ± 0.4 | |||
Normal | M | 32 | > 128 | 3.76 (94) | No | No |
Normal | F | 38 | > 128 | 3.27 (n/a) | No | No |
Normal | M | 23 | > 128 | n/a | No | No |
Normal | M | 50 | > 256 | 4 (80) | No | No |
Normal | M | 32 | 25.5 | 4.01 (122) | No | No |
Normal | F | 26 | 96 | 2.93 (95) | No | No |
Normal | M | 29 | 17.7 | 3.82 (89) | No | No |
Normal | M | 23 | > 128 | 5.06 (103) | No | No |
Mean | 31.6 ± 9.0 | 3.8 ± 0.7 |